nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are we “ONTARGET” yet with regard to optimal antihypertensive regimens?
|
Weir, Matthew R. |
|
2008 |
10 |
5 |
p. 385-386 |
artikel |
2 |
Behavioral cardiology: Recognizing and addressing the profound impact of psychosocial stress on cardiovascular health
|
Das, Sajal |
|
2008 |
10 |
5 |
p. 374-381 |
artikel |
3 |
Clinical trials report
|
Bakris, George L. |
|
2008 |
10 |
5 |
p. 387-389 |
artikel |
4 |
Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?
|
Nasser, Samar A. |
|
2008 |
10 |
5 |
p. 398-404 |
artikel |
5 |
Does socioeconomic status affect blood pressure goal achievement?
|
Minor, Deborah |
|
2008 |
10 |
5 |
p. 390-397 |
artikel |
6 |
Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure?
|
Sica, Domenic A. |
|
2008 |
10 |
5 |
p. 415-420 |
artikel |
7 |
Hypertension management in patients with chronic kidney disease
|
Palmer, Biff F. |
|
2008 |
10 |
5 |
p. 367-373 |
artikel |
8 |
Literature alert
|
|
|
2008 |
10 |
5 |
p. 339 |
artikel |
9 |
Management of hypertension in patients with coronary artery disease
|
Vongpatanasin, Wanpen |
|
2008 |
10 |
5 |
p. 349-354 |
artikel |
10 |
New guidelines of the European society of hypertension
|
Segura, Julian |
|
2008 |
10 |
5 |
p. 337-338 |
artikel |
11 |
ONTARGET study of telmisartan, ramipril, or both in high-risk patients
|
Ram, C. Venkata S. |
|
2008 |
10 |
5 |
p. 345-348 |
artikel |
12 |
Pharmacologic modulation of ACE2 expression
|
Soler, María José |
|
2008 |
10 |
5 |
p. 410-414 |
artikel |
13 |
Pharmacologic modulation of ACE2 expression
|
Soler, María José |
|
|
10 |
5 |
p. 410-414 |
artikel |
14 |
Prehypertension: Risk stratification and management considerations
|
Egan, Brent M. |
|
2008 |
10 |
5 |
p. 359-366 |
artikel |
15 |
Recent advances in automated blood pressure measurement
|
Myers, Martin G. |
|
2008 |
10 |
5 |
p. 355-358 |
artikel |
16 |
Renin receptor blockade: A better strategy for renal protection than renin-angiotensin system inhibition?
|
Müller, Dominik N. |
|
2008 |
10 |
5 |
p. 405-409 |
artikel |
17 |
Telmisartan, ramipril, or both in patients at high risk for vascular events
|
Vidt, Donald G. |
|
2008 |
10 |
5 |
p. 343-344 |
artikel |